Mr. Leon Recanati
Chairman of The Investment Committee
Mr. Recanati is one of Israel's premier business figures and is currently the Chairman and CEO of GlenRock Israel. Prior to founding GlenRock in 2003, he served as Chairman and CEO of IDB Holding Corporation Ltd., one of the largest investment companies in Israel; Chairman of Clal Industries and Investments Ltd.; and Chairman of Azorim Investment Development and Construction Ltd. Until 1997, Mr. Recanati was Chairman of Delek Israel Fuel Corporation and Chairman of Super-Sol (a leading Israeli retail corporation), in addition to holding several other positions at a variety of operating companies in Israel.
Mr. Efi Cohen-Arazi Chairman
Mr. Cohen-Arazi has over 20 years of experience in the medical and biotech industries involving executive management responsibility for both development and business. Prior to establishing Rainbow Medical, Mr. Cohen-Arazi served as CEO of IntecPharma, Israel, a company specializing in drug development and delivery. Previously, Mr. Cohen-Arazi was V.P. Corporate Manufacturing, Head of Contract Manufacturing and Site Head at U.S.-based Amgen Corporation, where he established and led several global strategic partnerships to develop and manufacture small molecules and biopharmaceuticals. Mr. Cohen-Arazi held senior positions at Immunex in the U.S. and at the Merck-Serono Group in Switzerland. Mr. Cohen-Arazi holds advanced degrees in Agriculture and Microbiology from the Hebrew University of Jerusalem.
Mr. Boris Kalandar
Mr. Kalandar is the founder of SVM Advisors, LLC, a 15-year-old boutique technology merchant bank, and SVM-Israel investment funds. He is also a co-founder of MentorTech Ventures, a top quartile VC firm focusing on University of Pennsylvania related companies. He is a former senior executive with SMG, Inc., which was named three times to the “Inc. 500” fastest growing companies list, and led its $50M private equity re-capitalization exit. Mr. Kalandar is an investment advisor to Ben Franklin Technology Partners and a board member of various med-tech companies, including NeuroDx, Eye-IC, Soft Tissue Regeneration, and Syntezza Molecular Detection.
Mr. Yossi Gross
Mr. Gross is a medical device industry visionary and one of its most experienced and successful entrepreneurs. Mr. Gross has founded or co-founded 27 medical device companies, providing innovative solutions to significant unmet medical needs, and has over 500 patent applications in his name.
Dr. Shula Recanati
Dr. Shula Recanati is a Managing Partner at GlenRock Israel, which specializes in capital investments in life sciences & technology.
She leads the organizational development support, and serves as a BOD member of GlenRock's Hi-Tech portfolio companies.
Shula holds a PhD in organizational psychology from Columbia University and has over 20 years of experience as an organizational development consultant.
Before joining GlenRock, Shula worked in Pitango Venture Capital. Her career also includes five years as an Internal organizational psychologist for Citicorp in New York.
Shula is deeply involved in community activities : She is Chairperson of the Board of the Educating for Excellence foundation, serves on the board of trustees at the Academic College of Tel-Aviv Yaffo, and is a BOD member of the Taub Center for Social Policy Studies in Israel.
Mr. Ori Elan
Mr. Elan took a leading role in founding Real Imaging, a medical device company which has created a comprehensive imaging solution for breast cancer detection. He currently serves as Executive Director of Real Imaging and is responsible for its equity financing transactions. Previously, Mr. Elan served as a Senior Consultant for POC, a company specializing in business strategy, programs, processes and projects. Mr. Elan has also founded a multinational medical device company with significant sales from the design and manufacture of a device to alleviate back pain. Since 2006 Mr. Elan has additionally been active in international real estate ventures.
Dr. Joel P. Wyler
Mr. Wyler is an entrepreneur with a broad range of knowledge and many years of experience in internationally operating companies, international trade, shipping and logistics. He currently serves as chairman of Granaria Holdings B.V.; as a director of Aegate Holdings Ltd.; as a partner in ACPI Investments Ltd.; as a Board Member of Cocon Vastgoed B.V.; as chairman of the European Advisory Board of Afiniti and as a director of IBEX Global.
Sir William (Bill) Castell
Sir Bill Castell brings to Rainbow Medical a wealth of experience in medical technology and healthcare business leadership. Until September 2015, Bill was the Chairman of the Wellcome Trust, a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. Prior to that, Bill was the President and CEO of GE Healthcare, the global medical diagnostics and biosciences business of GE, of which he was also a Vice Chairman. Before its acquisition by GE in April 2004, Bill served as CEO of Amersham plc establishing it as a world leader in in vivo medical diagnostics and life sciences research technologies. He currently also serves as founding chair of the Foundation for Future London and Chairman of Chichester Festival Theatre.